HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth

por van Schooten, Jelle, van Gils, Marit J.
Publicado 2018

Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention

por Wagh, Kshitij, van Gils, Marit J., Gristick, Harry, Schommers, Philipp
Publicado 2021

Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals

por Euler, Zelda, van Gils, Marit J., Boeser-Nunnink, Brigitte D., Schuitemaker, Hanneke, van Manen, Daniëlle
Publicado 2013

Natural infection as a blueprint for rational HIV vaccine design

por van Haaren, Marlies M., van den Kerkhof, Tom L. G. M., van Gils, Marit J.
Publicado 2016

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation

por van der Straten, Karlijn, van Gils, Marit J., de Taeye, Steven W., de Bree, Godelieve J.
Publicado 2022

Maternal Stress and Human Milk Antibodies During the COVID-19 Pandemic

por Juncker, Hannah G., Ruhé, Eliza J. M., Korosi, Aniko, van Goudoever, Johannes B., van Gils, Marit J., van Keulen, Britt J.
Publicado 2022

HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans

por Malherbe, Delphine C., Sanders, Rogier W., van Gils, Marit J., Park, Byung, Gomes, Michelle M., Schuitemaker, Hanneke, Barnett, Susan, Haigwood, Nancy L.
Publicado 2013

Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans

por Aartse, Aafke, Eggink, Dirk, Claireaux, Mathieu, van Leeuwen, Sarah, Mooij, Petra, Bogers, Willy M., Sanders, Rogier W., Koopman, Gerrit, van Gils, Marit J.
Publicado 2021

Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations

por Mulleners, Sien J., Juncker, Hannah G., Ruhé, Eliza J. M., Korosi, Aniko, van Goudoever, Johannes B., van Gils, Marit J., van Keulen, Britt J.
Publicado 2023

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface

por Torrents de la Peña, Alba, del Moral Sánchez, Iván, Burger, Judith A., Bontjer, Ilja, Isik, Gözde, Eggink, Dirk, van Gils, Marit J., Sanders, Rogier W.
Publicado 2021

From affinity selection to kinetic selection in Germinal Centre modelling

por Lashgari, Danial, Merino Tejero, Elena, Meyer-Hermann, Michael, Claireaux, Mathieu A. F., van Gils, Marit J., Hoefsloot, Huub C. J., van Kampen, Antoine H. C.
Publicado 2022

Signatures of V(H)1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins

por Capella-Pujol, Joan, de Gast, Marlon, Radić, Laura, Zon, Ian, Chumbe, Ana, Koekkoek, Sylvie, Olijhoek, Wouter, Schinkel, Janke, van Gils, Marit J., Sanders, Rogier W., Sliepen, Kwinten
Publicado 2023

Physical activity in lactating women influences SARS-CoV-2-specific antibodies in human milk

por Juncker, Hannah G., van Doesburg, Maritt, de Groot, Christianne J.M., Pajkrt, Dasja, Korosi, Aniko, van Gils, Marit J., van Goudoever, Johannes B., van Keulen, Britt J.
Publicado 2023

Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users

por EULER, Zelda, VAN DEN KERKHOF, Tom L., KOUYOS, Roger D., TULLY, Damien C., ALLEN, Todd M., TRKOLA, Alexandra, SANDERS, Rogier W., SCHUITEMAKER, Hanneke, VAN GILS, Marit J.
Publicado 2019

Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics

por Torrents de la Peña, Alba, Rantalainen, Kimmo, Cottrell, Christopher A., Allen, Joel D., van Gils, Marit J., Torres, Jonathan L., Crispin, Max, Sanders, Rogier W., Ward, Andrew B.
Publicado 2019

Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections

por Sechan, Ferdyansyah, Grobben, Marloes, Edridge, Arthur W. D., Jebbink, Maarten F., Loens, Katherine, Ieven, Margareta, Goossens, Herman, van Hemert-Glaubitz, Susan, van Gils, Marit J., van der Hoek, Lia
Publicado 2022

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds

por van den Kerkhof, Tom L. G. M., de Taeye, Steven W., Boeser-Nunnink, Brigitte D., Burton, Dennis R., Kootstra, Neeltje A., Schuitemaker, Hanneke, Sanders, Rogier W., van Gils, Marit J.
Publicado 2016

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity

por van den Kerkhof, Tom L G M, Feenstra, K Anton, Euler, Zelda, van Gils, Marit J, Rijsdijk, Linda W E, Boeser-Nunnink, Brigitte D, Heringa, Jaap, Schuitemaker, Hanneke, Sanders, Rogier W
Publicado 2013

Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection

por Juncker, Hannah G., Mulleners, Sien J., van Gils, Marit J., Bijl, Tom P. L., de Groot, Christianne J. M., Pajkrt, Dasja, Korosi, Aniko, van Goudoever, Johannes B., van Keulen, Britt J.
Publicado 2021

Visualization of the HIV-1 Env glycan shield across scales

por Berndsen, Zachary T., Chakraborty, Srirupa, Wang, Xiaoning, Cottrell, Christopher A., Torres, Jonathan L., Diedrich, Jolene K., López, Cesar A., Yates, John R., van Gils, Marit J., Paulson, James C., Gnanakaran, Sandrasegaram, Ward, Andrew B.
Publicado 2020